Liraglutide biosimilar(Nobot Biotechnology)

Main research purpose: This study uses liraglutide injection (3ml: 18mg) produced by Beijing Nobot Biotechnology Co., Ltd. as the test preparation (T), and liraglutide injection (3ml: 18mg, trade name: Novo®) produced by the original manufacturer Novo Nordisk of Denmark as the reference preparation (R) to evaluate the pharmacokinetic similarity of the test preparation (T) and the reference preparation (R). Secondary research purpose: To observe the safety and immunogenicity of the test preparation (T) and the reference preparation (R) in healthy subjects.